期刊文献+

NRG1转染对骨髓基质干细胞表达VEGF的影响 被引量:1

Influence of NRG1 transfection on expression of VEGF in bone marrow stromal stem cells
下载PDF
导出
摘要 目的探讨神经调节因子1(neuregulin-1,NRG1)转染是否可以促进骨髓基质干细胞(bone marrow stromal cells,BMSCs)表达血管内皮生长因子(vascular endothelial growth factor,VEGF)。方法提取与培养3只SD大鼠的BMSCs,采用NRG1质粒转染BMSCs并提取上清液,采用ELISA法测定转染组上清液中VEGF的含量,将非转染BMSCs的样本作为对照组,采用免疫组化方法检测细胞VEGF的表达。结果 BMSCs多数细胞处于伸展状态,呈梭形;经ELISA方法检测,转染组上清液VEGF的含量随时间增加呈增长趋势,与对照组比较,差异有统计学意义(P<0.05);经免疫组化检测,转染组细胞VEGF阳性率为91.07%,对照组细胞阳性率为70.82%,差异有统计学意义(P<0.05)。结论 NRG1转染可以促进BMSCs表达VEGF。 Objective To explore whether bone marrow stromal stem ceils (BMSCs) could been promoted by NRG1 transfection to VEGF expression.Methods The BMSCs of three SD rats were isolated and cultured,BMSCs were transfeeted with NRG1 plasmids,and the supernates were extracted.The contents of VEGF in the supernates were detected by the method of ELISA,and the samples of BMSCs were regarded as the control group.The expression of VEGF in BMSCs was detected by immunohistochemical method.Results Most of BMSCs were stretched and spindle-shaped.The levels of VEGF in the transfection group were increased with time by ELISA detection,compared with the control group,there was significant difference (P〈0.05).The VEGF positve cell rate of the transfection group was 91.07% by immunohistochemi- cal detection,while the positive cell rate of the control group was 70.82%,there was significant difference compared with the control group (P〈0.05).Coneluslon BMSCs can promoted by NRG1 transfection to express VEGF.
出处 《中国当代医药》 2017年第32期4-7,共4页 China Modern Medicine
基金 黑龙江省大学生创新创业训练计划项目(201610229031)
关键词 骨髓基质干细胞 细胞培养 血管内皮生长因子 神经调节因子1 Bone marrow stromal cells Cell culture Vascular endothelial growth factor Neuregulin-1
  • 相关文献

参考文献5

二级参考文献69

  • 1Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med, 2006, 12: 459-465.
  • 2Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet,2003, 361:45-46.
  • 3Mark FB, Adam JE, Joseph YW, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol,2006, 290: H2196-H2203.
  • 4Geng YJ. Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci,2003,1010: 687-697.
  • 5Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med, 2003, 9:1195-1201.
  • 6Calabro P , Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol,2005, 20: 541-546.
  • 7Endres M. Statins: potential new indications in inflammatory conditions. Atheroscler Suppl, 2006, 7: 31-35.
  • 8Hong MK, Lee CW, Kim YH, et al. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atheroscterotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy. Am J Cardiol,2006, 98: 866-870.
  • 9Chen MS, Xu FP, Wang YZ, et al. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis. J Mol Cell Cardiol,2004, 37:889-896.
  • 10Zhu WQ, Chen JH, Cong XF, et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells,2006, 24:416-425.

共引文献24

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部